Abstract We generated a high riboflavin-producing mutant strain of Ashbya gossypii by disparity mutagenesis using mutation of DNA polymerase δ in the lagging strand, resulting in loss of DNA repair function by the polymerase. Among 1,353 colonies generated in the first screen, 26 mutants produced more than 3 g/L of riboflavin. By the second screen and single-colony isolation, nine strains that produced more than 5.2 g/L of riboflavin were selected as high riboflavin-producing strains. These mutants were resistant to oxalic acid and hydrogen peroxide as antimetabolites. One strain (W122032) produced 13.7 g/L of riboflavin in a 3-L fermentor using an optimized medium. This represents a ninefold improvement on the production of the wild-type strain. Proteomic analysis revealed that ADE1, RIB1, and RIB5 proteins were expressed at twofold higher levels in this strain than in the wild type. DNA microarray analysis showed that purine and riboflavin biosynthetic pathways were upregulated, while pathways related to carbon source assimilation, energy generation, and glycolysis were downregulated. Genes in the riboflavin biosynthetic pathway were significantly overexpressed during both riboflavin production and stationary phases, for example, RIB1 and RIB3 were expressed at greater than sixfold higher levels in this strain compared to the wild type. These results indicate that the improved riboflavin production in this strain is related to a shift in carbon flux from β-oxidation to the riboflavin biosynthetic pathway.
Introduction
Riboflavin is a water-soluble vitamin, also known as vitamin B 2 . It is a precursor of the coenzymes flavin mononucleotide and flavin adenine dinucleotide, which are essential for the transfer of electrons in oxidation-reduction reactions (Schmidt et al. 1996) . It is also essential for the health of the mucous membrane in the digestive tract and helps with the absorption of iron and vitamin B6 in the human body and animals.
Fermentation of Ashbya gossypii yields an output of more than 4,000 metric tons/year, which represents about 50% of commercial riboflavin production in the world (Chotani et al. 2007 ). Efforts on improving riboflavin production of A. gossypii yielded up to 15 g/L riboflavin by chemical mutagenesis more than two decades ago (Bigelis 1989) . Riboflavin is synthesized from guanosine-5-triphosphate (GTP) and ribulose 5-phosohate by RIB genes. From oils, GTP and ribulose 5-phosohate are supplied through β-oxidation, glyoxylate cycle, gluconeogenesis, pentosephosphate pathway, and purine biosynthetic pathway (Fig. 1 ). Glyoxylate pathway is important for riboflavin synthesis from oils. Isocitrate lyase (ICL, threo-D s -isocitrate glyoxylate-lyase, EC 4.1.3.1) in glyoxylate cycle is the key enzyme involved in this anaplerotic pathway in A. gossypii (Schmidt et al. 1996) . A. gossypii is able to metabolize waste edible oils (Park et al. 2004 ) converting them into riboflavin via various cycle pathways. We attempted to improve the riboflavin production of A. gossypii using classical mutagenesis by ultraviolet (UV) radiation or by the chemical mutagen, N-methyl-N′-nitro-N-nitrosoguanidine (NTG) (Tajima et al. 2009 ), but the riboflavin productivity of these mutants was found to be unstable.
Disparity mutagenesis was introduced by Furusawa and Doi (1998) and disparity theory has been developed using computer simulations (Furusawa and Doi 1992) . This technology increases the error threshold without the loss of genetic information by many-times division of cells and without damage on cell growth, yielding a large number of advantageous mutants (Shimoda et al. 2006; Abe et al. 2009 ). The disparity mutagenesis technique is capable of carrying out genomic mutations, including mutations in noncoding regions of the genome. This approach is particularly useful when there is no information on which specific genes or regions of the genome would result in the desired phenotype upon mutation. To obtain genetic diversity, an error-prone DNA polymerase technique is employed. Thus, a mutation is inserted into DNA polymerase δ which is responsible for synthesis of the lagging strands, such that the polymerase loses its DNA repair function (Aoki and Furusawa 2001) .
In this study, a high riboflavin-producing strain of A. gossypii was generated using disparity mutagenesis technique. Proteomic and DNA microarray analysis demonstrated the upregulation of genes involved in purine and riboflavin synthetic pathways, which accounts for the ninefold improvement in riboflavin production observed in the mutant strain, compared with production in the wild-type strain.
Materials and methods

Strains and culture methods
A. gossypii ATCC 10895 was used as the wild-type strain (WT) and was grown on YD medium (pH 6.8) containing 1% (w/v) yeast extract (Oriental Yeast Co., Ltd., Tokyo, Japan) and 1% (w/v) glucose (Wako Pure Chem. Ind., Ltd., Osaka, Japan) for sporulation and long-term storage at 4°C. YR medium (pH 6.8) containing 1% (w/v) yeast extract and 1% (w/v) rapeseed oil (Wako Pure Chem. Ind. Ltd., Osaka, Japan) was used as the screening medium for riboflavin production in test tube.
For preculture of riboflavin production, a seed medium consisting of 30 g/L corn steep liquor (CSL, Nihon Shokuhin Kako Co. Ltd., Tokyo, Japan), 9 g/L yeast extract, and 15 g/L rapeseed oil (pH 6.8) was used. The riboflavin production medium consisted of 60 g/L CSL, 30 g/L gelatin (Wako),
, and 50 g/L rapeseed oil (pH 6.8). Mineral ions were prepared as follows, 0.8812 g CoCl 2 , 3.602 g MnCl 2 ·4H 2 O, 8.795 g ZnSO 4 ·7H 2 O, and 2.028 g MgSO 4 ·7H 2 O were dissolved in 200 ml of distilled water, respectively. Each stock solution 1 ml was added to 1 L of production medium before autoclave. The flask cultures were prepared in 500-ml Erlenmeyer flasks with a working volume of 50 ml of each medium in a rotary shaker with 7 cm of rotating diameter (BIO SHAKER; Takasaki Inst. Co., Tokyo, Japan) at 220 rpm and 28°C. Riboflavin production was carried out in a 3-L bioreactor (Bioneer-300, Marubishi Co., Ltd., Tokyo, Japan) with a working volume of 1.5 L of production medium. The inoculum dose in each culture was 10% (v/v). Agitation and aeration rates used were 600 rpm and 1 vvm, respectively. Temperature was controlled at 28±0.5°C but pH was not controlled. Dissolved oxygen concentration and pH were recorded during the cultivation.
Disparity mutagenesis
Vector construction
Vector for disparity mutagenesis of A. gossypii was constructed as follows; LEU2 (1.2 kb) of YCplac111 (Gietz and Sugino 1988) was excised using Aat II and EcoR V, and then Geneticin resistance gene cassette (2.5 kb) was inserted into the BamH I restriction site of the multicloning site. The resulting plasmid was designated as YCpG418. The Ashbya DNA polymerase δ genome sequence, POL3 (AFL189W) was obtained from Ashbya database (http:// agd.vital-it.ch/Ashbya_gossypii/geneview?db=core; gene=AFL189W). This putative POL3 consisted of promoter (1 kb), POL3 (3.3 kb), and terminator (0.6 kb). Two nucleotides of the POL3 gene were mutated using PCR: 946 bp (A→C) and 952 bp (A→C). The resulting mutated POL3 (4.9 kb) was inserted into the Xba I site of YCpG418, and the resulting plasmid was designated as YCpG418/ pold exo− (Neo-Morgan, Tokyo; Supplementary file 1). Disparity mutagenesis technology involves transformation of the YCpG418/pold exo− and screening of transformants and the procedures (Fig. 2) are described in the following sections.
Transformation
Spores of the WT (approximately 1.0 ×10 6 ) were grown on YD medium for 27 h. The mycelia were harvested by filtration, washed with distilled water, and suspended in 50 mM potassium phosphate buffer (pH 6.8) containing 25 mM 2-mercaptoethanol. The suspension was incubated at 30°C for 30 min with gentle agitation and the mycelia were collected by filtration and washed with transformation buffer consisting of 270 mM sucrose, 10 mM Tris-HCl (pH 7.5), and 1 mM MgCl 2 . The mycelia were finally resuspended in cooled transformation buffer, and 350 μl of the mycelial suspension was mixed with 1.5 μl of the plasmid YCpG418/pold exo− . This plasmid was introduced into the mycelium by electroporation in a Gene Pulser Xcell system (Bio-Rad Lab. Inc., Hercules, CA, USA) at 1.5 kV/cm, 100 Ω, and 25 μF using 2 mm prechilled electrocuvettes (Bio-Rad). The post-electroporated mycelia were plated and incubated on a YD plate to regenerate the mycelia at 28°C for 6 h. Subsequently, the mycelia were covered with 20 ml YD medium containing 0.6% agar and 200 μg/ml Geneticin for isolation of the transformants. After 3-6 days incubation, the Geneticin-resistant spores germinated on the bottom and elongated mycelia reached above the surface of the agar. Likewise, Geneticin-resistant colonies were picked and transferred into a new YR plate containing 200 μg/ml Geneticin (G418-YR).
Regeneration and screening procedures
The mycelia produced in the G418-YR plate are designated as the first generation. Colonies of the first generation were picked and transferred to a new G418-YR plate, and was then designated the second generation. This procedure was On the other hand, picked colonies from each generation were also inoculated into 5 ml of YR medium in a test tube and cultured twice in YR medium without Geneticin to release the plasmid from the transformants. Until the 18th generation, YR medium was used; but from the 19th to the 30th generation, modified YR medium (containing 2% (w/v) rapeseed oil and 3% (w/v) yeast extract) was used to avoid nutrient depletion. The test tube cultures were carried out at 28°C with 150 rpm for 24 h.
The first screening of mutants was carried out using the YCpG418/pold exo− -losing colonies (Supplementary file 2). One hundred microliter of the YCpG418/pold exo− -losing cell suspension was transferred into a new 5 ml YR medium in a test tube, and cultured at 28°C, 150 rpm for 6 days. After culture, the riboflavin concentration was measured and if the colony proved to be a high-riboflavin producer, it was frozen at −20°C for the second screening.
For the second screening, the colonies from the frozen stock were transferred into 5 ml of a seed medium in a test tube at 28°C and 200 rpm and shaken for 24 h (Supplementary file 2). Ten percent of the seed culture was inoculated into a 500-ml Erlenmeyer flask containing 50 ml of the production medium (pH 6.8). Cultivation was conducted at 28°C and 220 rpm for 6 days. All mutant strains were also stored in a −80°C freezer in the presence of 20% (v/v) glycerol.
Medium optimization
The effect of CSL, yeast extract, rapeseed oil, soybean mill, glycine, alanine, and glutamic acid in the production medium on riboflavin production was investigated using a two-level factor design. CSL, yeast extract, rapeseed oil, glycine, and glutamic acid were selected as the most effective composition for riboflavin production, and reoptimized using three-level factor design (Box-Behnken). CSL and yeast extract were extracted to be the most important nitrogen sources and their levels were optimized for riboflavin production by three-level factor design. Statistical analysis was performed with STATISTICA (StatSoft Inc., OK, USA), and the regression of the parameters was solved using Mathcad 2001 Professional (Mathsoft Engineering and Education, Inc., MA, USA).
Proteomic analysis
The WT and mutant strains were grown in YR medium in 500-ml Erlenmeyer flasks with a working volume of 50 ml at 28°C for 4 days. The mycelia were harvested, washed twice with sterile distilled water and suspended in 50 mM potassium phosphate buffer (pH 6.0). Subsequently, the mycelia were sonicated on ice five times at 40 W for 30 s with 1-min interval, using an ultrasonicator (Sonics & Materials Inc., CT, USA), to extract the intracellular soluble proteins. The sample was centrifuged at 20,000×g and 4°C for 5 min and the supernatant containing the soluble proteins was used for 2D electrophoresis proteomic analysis (performed at Shimadzu Techno-Research Inc., Kyoto, Japan). Isoelectric focusing (IEF) was performed between pH 3 and 10 using Immobiline DryStrip gel (GE Healthcare Japan, Tokyo, Japan). After IEF, the gel was equilibrated with sample buffer (6 M urea, 20% glycerol, 2% dithiothreitol, 2% sodium dodecyl sulfate 100 mM Tris-HCl pH 8.8) and applied to 10-18% polyacrylamide gradient gel. Gels were stained with Coomassie Brilliant Blue (CBB). Some scraps of gels stained with CBB were picked up and proteins were digested by trypsin. Samples were applied to peptide mass fingerprinting analysis. For 2D electrophoresis, 250 μg of protein was used.
DNA microarray
The WT and mutants were used for DNA microarray testing. The harvested mycelia were frozen at −80°C and used for RNA extraction. RNA extraction was performed and RNA quality was checked by Nihon Gene Research Lab. Inc. (Sendai, Japan). Custom arrays of A. gossypii were manufactured by Roche NimbleGen Inc. (Tokyo, Japan) using 4×72 K (4 plex) format. For each gene, six different oligonucleotides were designed and every oligonucleotide was repeated twice on each slide. Each slide contained all (4726) ORFs of A. gossypii. Double-stranded cDNAs were synthesized using oligo-dT and labeled with Cy3 dye. Labeled cDNA was hybridized to custom arrays and data were extracted by NimbleGen software and analyzed by DNASTAR ArrayStar v3.0 (Madison, WI, USA).
Analytical methods
Concentrations of riboflavin, residual oil, and dry cell weight were measured according to previous report (Park et al. 2004) . Protein concentration was measured using Protein Assay Kit II (Bio-Rad Lab. Inc.) based on Bradford method.
Results
Disparity mutagenesis
From the first to the 30th generation, 1,851 Geneticin-resistant colonies were obtained; and of those mutants, 1,353 mutants showing deep yellow colonies were selected as riboflavin producing mutants during the first screening process. From the first to the 18th generation, YR broth medium was used. Between the first and 18th generation, the mutant of 15th generation produced the highest riboflavin concentration. Therefore, from the 19th generation, a modified YR broth medium was used to avoid carbon source depletion. Riboflavin concentration increased between 19th and 23rd generations. However, until 30th generation, riboflavin production decreased. The highest riboflavin concentration was obtained in 23rd generation and no further increase in production was observed in later mutants. The first screening was therefore stopped at the 30th generation. The maximum riboflavin concentration observed in the first screening in test tubes was 2 g/l.
In the second screening process, 26 mutants were picked up from the 1,353 mutants chosen during the first screen. These 26 mutants produced around 3-4 g/L of riboflavin at the second screening in the 500-ml Erlenmeyer flask cultivation. Single cell colonies of these 26 mutants were isolated and nine colonies were picked as the highest riboflavin producing mutants (Supplementary file 2). Single-cell colony isolation was repeated three times and the results of typical nine mutants are shown in Table 1 . Riboflavin concentration increased gradually from 3.5 to 5.8 g/l with repeated isolation. Riboflavin production in two mutants (W114038 and W122044) was less than 4.5 g/l, and they were not screened any further.
The effect of antimetabolites, such as oxalate and hydrogen peroxide, on the riboflavin production of these mutants was investigated. WT120015 and W122032 mutants grown in a medium containing 50 mM of oxalate both produced riboflavin in concentrations of around 60% of the concentration obtained without oxalate supplementation (data not shown). The wild-type strain, on the other hand, only produced around 10% of riboflavin when subjected to oxalate supplementation. In the case of hydrogen peroxide (0-40 mM), riboflavin production levels of each mutant changed only negligibly, with the exception of the W111024 mutant whose production was reduced to around 60% when hydrogen peroxide levels were highest (data not shown). However, the wild type showed a significant decrease in riboflavin production in the presence of hydrogen peroxide, dropping to 20% with the highest concentrations of hydrogen peroxide tested. These data show that these mutants are resistant to antimetabolites. From these results, the W122032 mutant was selected as the best riboflavin producer.
The stability of riboflavin production in the W122032 mutant was investigated on a flask scale. A glycerol stock of the W122032 strain was used for seed cultivation. The seed culture was used for its riboflavin production in a 500-ml flask scale and to make a new glycerol stock. This new glycerol stock was designated as the second generation. The second generation of glycerol stock was used for the next cultivation, and stocked the third glycerol stock. These steps were repeated until 14 generations had been generated. The W122032 strain showed good stability, producing riboflavin at concentrations of around 5-6 g/l until the 14th generation (Fig. 3) . The standard deviation of riboflavin production from the first to the 14th generation was 0.25, suggesting that the W122032 mutant was a stable producer of riboflavin.
Medium optimization and riboflavin production in a bioreactor
Conventional media contain gelatin, which is of animal origin, and gelatin is a useful nitrogen source in microbial fermentation. However, to substitute a safe nitrogen source, several nitrogen sources of plant origin were tested and soybean mill was chosen (data not shown). Since the production medium contained rapeseed oil, glycine, CSL, yeast extract, glutamic acid, and mineral components, the composition of the production medium was optimized using Box-Behnken experimental design. Since CSL and yeast extract were the most effective nitrogen sources in riboflavin production, these two nitrogen sources were reoptimized and optimal concentrations of these components were determined to be 40.3 and 36.1 g/l, respectively. The optimized composition of the production medium is shown in Table 2 . When the W122032 mutant was cultured in the optimized medium in a 3-L fermentor, riboflavin production was significantly improved. Dissolved oxygen level during the culture of W122032 strain was below 10% for 3 days and gradually increased (Fig. 4a) while it was only 1 day in the wild-type strain. pHs of both strains remained 6.5-7.5 throughout the cultures (Fig. 4a) . For the riboflavin production, the wild-type strain produced 1.5 g/l for 5 days, while the W122032 strain produced 7.2 g/l in conventional medium for 8 days and 13.7 g/l in optimized medium for 9 days, respectively (Fig. 4b) . When the culture was repeated 3 months later, under the same conditions, the riboflavin concentration was 13.4 g/l for 9 days (triangles in Fig. 4b ). The quantity of rapeseed oil consumed in two cultures of W122032 was 73 and 75 g/l, while it was 79 g/l in the wildtype strain. This indicates that this strain is a very stable and high-riboflavin producer in a bioreactor. Riboflavin yield based on the consumed carbon source of the wild-type strain was 0.02 (g riboflavin/g consumed carbon source) while that of W122032 was 0.18 g/g. The W122032 mutant had a riboflavin yield ninefold higher than the wild-type strain.
Proteomic analysis
To establish the differences between the wild-type and mutant strains, proteomic analysis was performed with about five mutants that produced riboflavin at concentrations higher than 5.7 g/l ( Table 1 ). Proteins that showed significant (fivefold) over-or underexpression compared to that of the wild-type strain are listed in Table 3 . Enzymes which showed increased expression were phosphoglycerate mutase, which catalyzes the reaction of 2-phosphoglycerate to 3-phosphoglycerate or vice versa in glycolysis, citrate synthase, which catalyzes citrate formation from oxaloacetate in the tricarboxylic acid (TCA) cycle, and NADP or NADPH binding oxidoreductase and oxidoreductase, which are involved in oxidation and reduction in mitochondria. On the other hand, phosphoribosylaminoimidazolesuccinocarboxamide synthase, GTP cyclohydrolase II, and riboflavin synthase all showed significantly increased expression.
Phosphoribosylaminoimidazole-succinocarboxamide synthase catalyzes the formation of [[(S)-2-[5-amino-1-(5-phospho-D-ribosyl)imidazole-4-]], and [[carboxamido]succinate]] (SAICAR) from 5-amino-1-(5-phospho-D-ribosyl)
imidazole-4-carboxylate in purine metabolism. GTP cyclohydrolase II is involved in the formation of 2,5-diamino-6-hydroxy-4-(5-phosphoribosylamino)pyrimidine from GTP in the riboflavin biosynthetic pathway. Riboflavin synthase converts 6,7-dimethyl-8-ribityllumazine to riboflavin in the riboflavin biosynthetic pathway. This suggests that Generation of W122032 strain Fig. 3 Stability of riboflavin production by the W122032 mutant on a flask scale. Glycerol stock was used in the culture and after culture a new glycerol stock was prepared then repeated 14 times Table 2 Optimized production medium (g/l) for high riboflavin producing mutant a pH was adjusted by 1 M KOH and 1 M HCl b Preparation of minerals was followed from "Strains and culture methods" section phosphoribosylaminoimidazole-succinocarboxamide synthase increases GTP flux from the purine biosynthetic pathway, and GTP cyclohydrolase II increases the flux of 2,5-diamino-6-hydroxy-4-(5-phosphoribosylamino)pyrimidine, which is an intermediate of riboflavin production. This increased carbon flux in the mutants was converted effectively into riboflavin by the increased activity of riboflavin synthase, which leads to improved riboflavin production in the mutants.
DNA microarray
Gene expression in mutant strains was compared to that of the wild type as shown in Fig. 5 . SPS19 and POT1, which are involved in the β-oxidation cycle, showed a twofold higher expression, while FAA1,4, POX1 and FOX1 had a twofold lower expression. Of the glyoxylate cycle enzymes, CIT1,2 was expressed at high levels, but MLS1, at low levels. Enzymes in the TCA, glycolysis, and pentose phosphate cycles were downregulated with the exception of CIT1,2 and ZWF1. Enzymes involved in the purine biosynthetic pathway showed a twofold increased expression with the exception of IMD3,4. Interestingly, RIB1, BIB2, RIB5, and RIB7 were expressed at more than twofold higher levels than in the wild type. Expression level of RIB3 was a threefold higher than that of wild-type strain. Overall, the gene expressions of purine and riboflavin biosynthetic pathways were upregulated but pathways related to carbon source assimilation, energy generation, and glycolysis were downregulated. Differences in gene expression during logarithmic growth, riboflavin production, and stationary phases of the mutant strain were compared with expression in the wild-type strain (Fig. 6a, b) . Gene expression involved in β-oxidation, Fig. 4 Dissolved oxygen (DO) and pH (a), and riboflavin production (b) in the cultures of W122032 mutant and wild-type strains using a 3-L bioreactor. Symbols in a time course of DO and pH in the culture of the wild-type and W122032 strains: plus sign DO of wild-type strain, minus sign DO of W122032 strain, dotted line pH of wild-type strain, straight line pH of W122032 strain. MT and WT denote W122032 mutant and wild strains, respectively. b Riboflavin production in the culture of the wild-type and W122032 strains: wild-type strain in conventional medium (open circles), the W122032 strain grown in conventional medium (closed circles), the W122032 strain grown in optimized medium (open squares), the W122032 strain grown in optimized medium after preservation for 3 months (closed triangles) 
↑ indicates more than fivefold increased expression compared to that of wild type ↓ indicates less than fivefold decreased expression compared to that of wild type glyoxylate, and TCA cycles in the mutant strain were decreased compared to expression levels in the wild-type strain. In the gluconeogenesis, expression of GLK1, HXK1,2, GMP2,3, 3-phosphoglycerate kinase (PGK1), ENO1,2, and PYK2 increased 1.5-fold in the mutant strain during the riboflavin-producing phase. PRS1, PRS3, and PRS5 in the pentose phosphate cycle were expressed at threefold higher levels during the riboflavin production phase compared to the wild type. In the purine biosynthetic pathway, ADE1, ADE5,7, and ADE6 were expressed twofold more during the logarithmic growth and stationary phases than in the wild type. Expression of GUA1, YND1, and GUK1 increased only during the stationary phase. In the riboflavin biosynthetic pathway, all enzymes were expressed at significantly higher levels than in the wild type. RIB1 during the riboflavin production and RIB3 during the stationary phase were expressed at levels more than sixfold higher than the wild type. The mutant strain therefore features
Fructose-6P
Glucose-6P
Glycerone-P
Glyceraldehyde-3P
Glycerate-3P Red letters indicate more than threefold increased expression compared with the wild-type strain; pink letters more than twofold and less threefold increased expression; orange letters less than twofold increased expression. Dark blue letters indicate more than threefold decreased expression to that of wild-type strain; purple letters more than twofold and less than threefold decreased expression; light blue letters less than twofold decreased expression. ACO1 acyl-CoA desaturase 1; ADE1 phosphoribosylamino-imidazolesuccinocarbozamide synthetase; ADE4 phosphoribosylpyrophosphate amidotransferase; ADE5 5′-phosphoribosylformyl glycineamide synthetase; ADE6 formylglycinamidine-ribonucleotide (FGAM)-synthetase; CDC19 pyruvate kinase; CIT1,2 citrate synthase; ENO1, 2 Enolase 1, 2; FAA1,4 fatty acyl-CoA synthetase; FBA1 fructose-1,6-bisphosphate aldolase; FBP1 fructose-1,6-bisphosphatase; FOX1 acyl-CoA oxidase; FUM1 fumarase; GLK1 glucose-specific glucokinase; GND1,2 6-phosphogluconate dehydrogenase; GPM1 phosphoglycerate mutase 1; GUA1 guanine monophosphate synthase; GUK1 guanylate kinase; HXK1 hexokinase; ICL1 isocitrate lyase; IDH1 NAD + -dependent isocitrate dehydrogenase; IMD3,4 inosine monophosphate dehydrogenase; LSC1,2 succinyl-CoA ligase; MDH3 malate dehydrogenase; MLS1 malate synthase; PCK1 phosphoenolpyruvate carboxykinase; PFK1 phosphofructokinase; PGI1 phosphoglucoisomerase; PGK1 3-phosphoglycerate kinase; POT1 3-ketoacyl-CoA thiolase; POX1 fatty acyl-CoA oxidase; PRS1-5 5-phospho-ribosyl-1(alpha)-pyrophosphate synthetase; RIB1 GTP cyclohydrolase I; RIB2 deaminase; RIB3 3,4-dihydroxy-2-butanone-4-phosphate (DHBP) synthase; RIB4 6,7-dimethyl-8-ribityllumazine (lumazine) synthase; RIB5 riboflavin synthase; RIB7 reductase; RKI1 ribose-5-phosphate ketol-isomerase; SDH1,2 succinate dehydrogenase; SOL1-4 6-phosphogluconolactonase; SPS19 2,4-dienoylCoA reductase; TDH3 glyceraldehyde-6-P-dehydrogenase; YND1 yeast nucleoside diphosphatase; ZWF1 glucose-6-phosphate dehydrogenase a highly activated purine and riboflavin biosynthetic pathway, which explains this mutant's improved riboflavin production.
Discussion
In previous studies, we reported our attempts to increase riboflavin production in A. gossypii using classical mutagenesis with UV radiation ) and chemical mutagenesis using NTG (Tajima et al. 2009 ). Whilst the filamentous hemiascomycete A. gossypii is sensitive to, and is mutated by UV light (Stahmann et al. 2001) , the mutant strain gradually lost its excess riboflavin productivity after 2 years of culture and preservation ). Chemical mutagenesis using NTG is used for classical strain improvement. A. gossypii 13a mutant was obtained using NTG mutation and produced threefold higher than that in the wild-type strain. However, the 13a mutant gradually lost its excess riboflavin productivity after preservation for a long period similar to the NTU-induced mutant (Tajima et al. 2009 ). Proteomic analysis revealed that the activities of ICL, mitochondrial aldehyde dehydrogenase (ALDH), cytosolic a Fig. 6 Time courses of the expression of each gene based on DNA microarray analysis of W122032 mutant. Blue, orange, and purple bars denote logarithmic growth phase, riboflavin production, and stationary phases, respectively. Logarithmic growth phase of WT and MT was 8 and 16 h, respectively; riboflavin production phase of WT and MT, 16 and 28 h; stationary phase of WT and MT, 36 and 56 h.
Red dotted lines indicate expression levels of wild-type strain. Abbreviations are the same as those in Fig. 5 . a β-Oxidation, glyoxylate cycle, pentose phosphate and purine biosynthetic pathways are highlighter using dotted lines. b Gluconeogenesis, TCA cycle, riboflavin biosynthetic pathways are highlighted using dotted lines ALDH, threonine aldolase, and catalase were increased in the mutant strain. ICL and threonine aldolase are known to be responsible for riboflavin production in A. gossypii (Kanamasa et al. 2007; Monschau et al. 1998; Schmidt et al. 1996) .
For the purpose of increasing riboflavin productivity, we speculated that disparity mutagenesis, a new genetic mutation technology, may prove to be a useful alternative. In this study, a YCpG418/pold exo− vector, which contained mutated Ashbya POL3 gene and is responsible for the disparity mutation (Supplementary file 1) , was used. The W122032 strain produced 13.7 g/l in optimized medium, which represents the highest levels of riboflavin productivity obtained to date, even when compared to our previous methods Sugimoto et al. 2010; Tajima et al. 2009 ). Our results indicate that the technique may be successfully applied in a variety of microorganisms.
Proteomic analysis revealed that ADE1, RIB1, and RIB5 of five mutants were expressed five times higher than in the wild type. ADE1 plays an important role in inosine-5-monophosphate production in the purine biosynthetic pathway. GTP cyclohydrolase II (RIB1) catalyzes the reaction of GTP to 2,5-diamino-6-(5-phosphoribosyl(amino)-4-pyrimidineone, and supplies carbon flux to the purine biosynthetic pathway. Riboflavin synthase (RIB5) converts 6,8-diemthyl-8-ribityl lumazine to riboflavin. The increased gene expression of this enzyme improves carbon flux from the purine biosynthetic b Fig. 6 (continued) pathway to the riboflavin biosynthetic pathway. This result explains the high riboflavin production observed in the W122032 mutant. Previous reports (Jimenez et al. 2005; reported that purine biosynthetic pathway is important for riboflavin synthesis in A. gossypii. Increase of ADE1ex-pression corresponds to the results of previous reports.
DNA microarray experiments are consistent with the results of proteomic analysis. Genes in β-oxidation, glyoxylation and TCA cycles in W122032 mutant at the riboflavin-producing phase were downregulated, but genes in gluconeogenesis and pentose phosphate cycles showed increased expression. However, genes in the purine and riboflavin biosynthetic pathway showed increased expression at levels more than twofold higher than those of the wild type. This gene expression may increase carbon flux to riboflavin synthesis which is also confirmed by time course studies of gene expression. A previous paper (Karos et al. 2004) reported that transcription rate of ADE1gene was decreased in A. gossypii at the riboflavin-producing phase and on the other hand, transcription rate of PGK1 was decreased. These results indicate that the purine synthetic pathway is important for riboflavin production in A. gossypii. This result corresponds to that of proteomic analysis.
In Bacillus subtilis strains, a number of strategies have been used to generate high level riboflavin-producing strains. These include enhancement of both gene dosages and the transcriptional levels of the riboflavin operon in mutants (Perkins et al. 1999) , the constitutive expression of key genes in the riboflavin biosynthetic pathway (Hümbellin et al. 1999) , enhancing generation and reducing maintenance metabolism (Zamboni et al. 2003) , increasing precursor supply by modulating carbon flow through the pentose phosphate pathway (Zamboni et al. 2004; Zhu et al. 2006) , and deregulation using knockout technology (Tännler et al. 2008) . However, these strategies cannot be applied directly to A. gossypii strains. The expression of RIB1 and RIB4 of the riboflavin biosynthetic pathway in the mutant was less than that of the wild-type strain during the stationary phase. This may limit further improvements in riboflavin production by acting as a bottleneck in the W122032 strain. Overexpression of RIB1 and RIB4 during the stationary phase may be one strategy to further improve riboflavin production in A. gossypii. While the riboflavin synthetic pathway in the W122032 strain was increased, genes involved in carbon source assimilation upstream of the riboflavin synthesis pathway were downregulated. Therefore, increasing the carbon flux to the riboflavin synthetic pathway would also be expected to further improve riboflavin production. Expression of lipases gene in W122032 would be useful for assimilation of the carbon source in β-oxidation cycle.
We have been able to generate a high-riboflavin producing strain of A. gossypii using disparity mutagenesis. Proteomic and DNA microarray analysis demonstrated the upregulation of genes involved in purine and riboflavin synthetic pathways, which accounts for the ninefold improvement in riboflavin production observed in the W122032 strain, compared with production in the wild-type strain.
